AstraZeneca’s initiative is highlighting Fasenra’s potential to manage eosinophilic asthma — a severe form of asthma that may not always respond to common asthma medications.
Pharma and health and wellness jurors for 2024 Cannes Lions are revealed
Currently, the Alpine drug is set to enter a Phase 3 clinical trial by the end of the year and studies of its application in renal indications and autoimmune cytopenias are ongoing.
Why AbbVie is making big bets on telling the story of its R&D investments
As part of this pivot in strategic communications, AbbVie is focusing its efforts on accelerating R&D and making cures a priority across various disease states.
J&J scoops up cardio medtech Shockwave Medical for $13.1B
Following closure of the deal, Shockwave will operate as a business unit within J&J MedTech and its financials will be reported into the parent’s cardiovascular portfolio.
Rx Rundown: Roivant Sciences, Genmab, Metsera and more